| |
|
|
|
 |
Lercanidipine side-chain |
|
|
Intermediate for Lercanidipine
[Product No.] M0007
[Chemical Name] 1-((3,3-diphenylpropyl)(methyl)amino)-2-methylpropan-2-ol
[Molecular Formula] C20H27NO
[Molecular Weight] 297.43
[CAS No.] 100442-33-9
[Content]  98%
[Appearance] Light Brown liquid |
 |
|
Zopiclone |
|
|
A non-benzodiazepine hypnotic, used to treat insomnia (trouble in sleeping)
[Product No.] F0003
[Chemical Name] 6-(5-chloropyrid-2-yl)-5-(4-methylpiperazin-1-yl)carbonyloxy-7-oxo-6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazine
[Molecular Formula] C17H17ClN6O3
[Molecular Weight] 388.81
[CAS No.] 43200-80-2
[Content] 98%
[Appearance] white or white-like powder |
 |
|
Eszopiclone |
|
|
A stereo isomer of the hypnotic agent Zopiclone, more effect and less side effect than racemic Zopiclone
[Product No.] F0004
[Chemical Name] 5S-6-(5-chloropyrid-2-yl)-5-(4-methylpiperazin-1-yl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
[Molecular Formula] C17H17ClN6O3
[Molecular Weight] 388.81
[CAS No.] 138729-47-2
[Content] 99%
[Appearance] white or white-like powder
|
 |
|
Sultamicillin Tosylate |
|
|
Antibiotic
[Product No.] F0006
[Chemical Name] [2S-[2a(2R*,5S*),5a,6?(S*)]]-6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]heptane-2-carboxylic acid [[(3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]hept-2-yl)carbonyl]oxy]methyl ester, S,S-dioxide mono (4-methylbenzenesulfonic acid)
[Molecular Formula] C25H30N4O9S2. C7H8O3S
[Molecular Weight] 766.86
[CAS No.] 83105-70-8
[Content] 98%
[Appearance] white to off-white crystalline powder |
 |
|
Galanthamine Hydrobromide |
|
|
A acetylcholinesterase inhibitor, used to treat Alzheimer's disease
[Product No.] F0007
[Chemical Name] [4aS-(4a?,6?,8aR*)]-4a,5,9,10,11,12-hexahydro-3-metho-xy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide
[Molecular Formula] C17H21NO3.HBr
[Molecular Weight] 368.27
[CAS No.] 357-70-0
[Content] 98%
[Appearance] White or white-like crystal powder |
 |
|
Narwedine |
|
|
Intermediate for Galanthamine
[Product No.] M0008
[Chemical Name] 3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzofuro[3a,3,2-ef][2]benzazepin-6-one
[Molecular Formula] C17H19NO3
[Molecular Weight] 285.37
[CAS No.]
[Content] 98%
[Appearance] White or white-like powder |
 |
|
Celecoxib |
|
|
Cyclooxygenase-2 specific inhibitor, used to treat arthritis
[Product No.] F0008
[Chemical Name] 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
[Molecular Formula] C17H14F3N3O2S
[Molecular Weight] 381.37
[CAS No.] 169590-42-5
[Content] 99%
[Appearance] White or white-like powder |
 |
|
Pamabrom |
|
|
Used to treat dysmenorrheal
[Product No.] F0009
[Chemical Name] 8-Bromotheophylline compound with 2-amino-2-methyl-1-propanol (1:1)
[Molecular Formula] C11H18BrN5O3
[Molecular Weight] 348.20
[CAS No.] 606-04-2
[Content] 72.2%??-bromotheophylline??6.6%24.6%??-amino-2-methyl-1-propanol??6.6% |
 |
|
Sildenafil Citrate |
|
|
Phosphodiesterase-5 (PDE-5) inhibitor, used to treat erectile dysfunction in men
[Product No.] F0010
[Chemical Name] 5-[2-Ethoxy-5-(4-methylpiperazin-1-yl-sulphonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazol[4,3d]pyrimidin-7-one citrate
[Molecular Formula] C22H30N6O4S.C6H8O7
[Molecular Weight] 474.58 (free base)
[CAS No.] 139755-83-2
[Content] 99%
[Appearance] White crystalline powder
|
 |
|
Tadalafil |
|
|
Phosphodiesterase-5 (PDE-5) inhibitor, used to treat erectile dysfunction in men
[Product No.] F0011
[Chemical Name] (6R-12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)-phenyl)-pyrazino[1',2':1,6]pyrido[3,4-b]indole- 1,4-dione
[Molecular Formula] C22H19N3O4
[Molecular Weight] 389.40
[CAS No.] 171596-29-5
[Content] 99%
[Appearance] White crystalline powder |
 |
|
Vardenafil dihydrochloride |
|
|
Phosphodiesterase-5 (PDE-5) inhibitor, used to treat erectile dysfunction in men
[Product No.] F0012
[Chemical Name] 2-(2-ethoxy-5-(4-ethylpiperazin-1-ylsulfonyl)phenyl)-5-methyl-7-propylimidazo[1,5-f][1,2,4]triazin-4(3H)-one dihydrochloride
[Molecular Formula] C23H32N6O4S.2(HCl)
[Molecular Weight] 561.52
[CAS No.] 224789-15-5
[Content] 99%
[Appearance] White or white-like powder |
 |
|
Escitalopram Oxolate |
|
|
Used to treat depression and generalized anxiety disorder
[Product No.] F0013
[Chemical Name] 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran-carbonitrile Oxalate
[Molecular Formula] C20H21FN2O.C2H2O4
[Molecular Weight] 414.43
[CAS No.] 219861-08-2
[Content] 98.5%
[(R)-Enantiomer] ??%
[Optical Rotation] +10.5? to + 15.5?(c=1,Methanol)
[Appearance] White crystalline powder |
 |
|
PBNB |
|
|
Intermediate for Citalopram and Escitalopram
[Product No.] M0009
[Chemical Name] 4-(4-(dimethylamino)-1-(3-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hydrobromide
[Molecular Formula] C20H24BrFN2O2
[Molecular Weight] 423.32
[CAS No.]
[Content] 98%
[Appearance] White or light yellow powder |
 |
|
Raloxifene Hydrochloride |
|
|
Used in the prevention and treatment of osteoporosis in postmenopausal women
[Product No.] F0014
[Chemical Name] [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1- piperidinyl)ethoxy]- phenyl]methanone hydrochloride
[Molecular Formula] C28H27NO4S.HCl
[Molecular Weight] 510.04
[CAS No.] 82640-04-8
[Content] 98%
[Melting Point] 257-259?C
[Appearance] White or white-like powder
|
 |
|
Tamsulosin hydrochloride |
|
|
Used to treat the symptoms of an enlarged prostate
[Product No.] F0015
[Chemical Name] (-)-(R)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide hydrochloride
[Molecular Formula] C20H28N2O5S.HCl
[Molecular Weight] 444.98
[CAS No.] 106463-17-6
[Content] 98%
[Optical Rotation] -4.0? (c=0.35, methanol)
[Melting Point] 227-229?
[Appearance] CWhite or white-like powder
|
 |
|
|
|
